Research HighlightsResearch Neurology Update: Epilepsy December 1, 2020 Caution is warranted with the use of antiseizure medications in the context of COVID-19 illness. Read more here. Neurology Update: Epilepsy was last modified: December 1st, 2020 by Anja BurlicaShare this...FacebookTwitterLinkedin previous post Neurology Update: Epilepsy next post Neurology Update: Epilepsy You may also like Neurology Update: Neuropathies September 30, 2019 Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. May 6, 2020 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection March 3, 2021 Activities of the EAN Scientific Panel ALS/FTD during the EAN Congress in Amsterdam November 20, 2017 Understanding the implications of SARS-CoV-2 re-infections on immune response milieu, laboratory tests and control measures against COVID-19 January 28, 2021 The EAN Scientific Committee April 1, 2019 Activities of the EAN Scientific Panel Neurotraumatology 2016/2017 September 11, 2017 Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19 April 1, 2021 Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission January 5, 2021 Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial April 1, 2021 Leave a Comment Cancel ReplyYou need to be logged in to comment. Please login to MyEAN on top.